Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age.

NCT01857206 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01857206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01857206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age.
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2013
Completion date
June 30, 2014
Enrollment
2,055 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

fever, influenza